New technologies in treatment of patients in the acute period of stroke

Among the causes of death, according to the World Health Organithation, 56.7% are cardiovascular; 14.4% - cancer, trauma, poisoning and other external causes - 10.7%. In this case, stroke takes second place, second only to coronary heart disease (CHD) with myocardial infarction. The most accessible of modern methods of treating patients with ischemic stroke is systemic thrombolytic therapy (TLT). Werner Hacke, one of the founders of the use of TLT in Europe, notes that systemic TLT has been studied much better than other methods of revascularization. This method is most accessible both economically and technically. Reperfusion therapy for cerebral infarction allows you to increase the chances of a favorable outcome in the form of a decrease in mortality and an increase in the number of individuals independent in daily life. The results of the analysis of thrombolytic therapy carried out in the primary vascular department are presented.